News

Drug Briefing: Osilodrostat

Views: 43     Author: Unibest Industrial     Publish Time: 2025-04-29      Origin: Site

facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
sharethis sharing button


Query Drug:Osilodrostat

Query Time:2025-04-29 09:47:02

*** Disclaimer *** The information provided here is sourced from resources such as Drugs.com, the Orange Book, etc., and is auto-generated by the Unibest Digital Center. The content is intended exclusively for pharmaceutical professionals. Unibest does NOT accept legal responsibility for ANY medical actions taken based on this information. ALWAYS consult with your doctor for medical advice. In addition, this product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.


About the Drug

Osilodrostat is used in adults to treat Cushing's disease that cannot be treated with pituitary surgery.

Related Diseases

Extra Information on Drug and Diseases

Drug osilodrostat

RXCUI: 2286252

May Treat

  • Cushing Syndrome

Similar Drugs

[may_treat] Cushing Syndrome

Source MEDRT

[Physiological Effect] Adrenal Cortical Activity Alteration

Source: MEDRT

[Mechanism of Action] Adrenal Steroid Synthesis Inhibitors

Source MEDRT

[Mechanism of Action] Cytochrome P450 Inhibitors

Source MEDRT

[Mechanism of Action] Cytochrome P450 2D6 Inhibitors

Source DAILYMED

[Mechanism of Action] Cytochrome P450 2D6 Inhibitors

Source FDASPL

[Mechanism of Action] Cytochrome P450 1A2 Inhibitors

Source DAILYMED

[Mechanism of Action] Cytochrome P450 1A2 Inhibitors

Source FDASPL

[Mechanism of Action] Cytochrome P450 2C19 Inhibitors

Source DAILYMED

[Mechanism of Action] Cytochrome P450 2C19 Inhibitors

Source FDASPL

[Mechanism of Action] Cytochrome P450 3A4 Inhibitors

Source DAILYMED

[Mechanism of Action] Cytochrome P450 3A4 Inhibitors

Source FDASPL

[Mechanism of Action] Cytochrome P450 3A5 Inhibitors

Source DAILYMED

[Mechanism of Action] Cytochrome P450 3A5 Inhibitors

Source FDASPL

[Phamacological Category] Cortisol Synthesis Inhibitor

Source DAILYMED

[Phamacological Category] Cortisol Synthesis Inhibitor

Source FDASPL

[Mechanism of Action] Cytochrome P450 11B1 Inhibitors

Source FDASPL

[Mechanism of Action] Cytochrome P450 11B1 Inhibitors

Source DAILYMED

Drug osilodrostat phosphate

RXCUI: 2286253

May Treat

  • Cushing Syndrome

Similar Drugs

[may_treat] Cushing Syndrome

Source MEDRT

[Physiological Effect] Adrenal Cortical Activity Alteration

Source: MEDRT

[Mechanism of Action] Adrenal Steroid Synthesis Inhibitors

Source MEDRT

[Mechanism of Action] Cytochrome P450 Inhibitors

Source MEDRT

Orange Book

[Last update] 2024-12-25

Labelers

Osilodrostat's Innovator is RECORDATI RARE DISEASES INC

Drug Products

The unique dosage forms from the innovator include:1. TABLET;ORAL.

Index Route Brand Name Labeler Approval Date Dosage
1 TABLET;ORAL ISTURISA RECORDATI RARE DISEASES INC Mar 6, 2020 EQ 10MG BASE
2 TABLET;ORAL ISTURISA RECORDATI RARE DISEASES INC Mar 6, 2020 EQ 1MG BASE
3 TABLET;ORAL ISTURISA RECORDATI RARE DISEASES INC Mar 6, 2020 EQ 5MG BASE

Drug Patents

This drug still has 6 effective patents.

Patent Number Submission Date Expiration Date Drug Substance Patent? Drug Product Patent?
8609862 Apr 3, 2020 Jan 13, 2031

10143680 Apr 3, 2020 Jul 6, 2035
Y
8835646 Apr 3, 2020 Aug 23, 2026 Y Y
8314097 Apr 3, 2020 Mar 27, 2029 Y Y
9434754 Apr 3, 2020 Jan 13, 2031 Y
10709691 Aug 6, 2020 Oct 12, 2035

Osilodrostat Patent Scope

Related Company's Product Pipelines

The innovator RECORDATI RARE DISEASES INC's portolio contains products with the following 12 API(s): CYSTEAMINE HYDROCHLORIDE, ETHOTOIN, IBUPROFEN LYSINE, PASIREOTIDE DIASPARTATE, MECHLORETHAMINE HYDROCHLORIDE, CARGLUMIC ACID, DACTINOMYCIN, BETAINE, INDOMETHACIN SODIUM, SUCCIMER, PASIREOTIDE PAMOATE, OSILODROSTAT PHOSPHATE

The above products are related to 48 diseases: Cystinosis, Epilepsy, Complex Partial, Seizures, Epilepsy, Tonic-Clonic, Spondylitis, Ankylosing, Arthritis, Rheumatoid, Inflammation, Gout, Arthritis, Juvenile, Menorrhagia, Fever, Osteoarthritis, Pain, Pain, Postoperative, Dysmenorrhea, Premenstrual Syndrome, Bursitis, Cushing Syndrome, Pleural Effusion, Malignant, Neoplasm Metastasis, Hodgkin Disease, Mycosis Fungoides, Hyperammonemia, Melanoma, Testicular Neoplasms, Choriocarcinoma, Sarcoma, Kaposi, Sarcoma, Ewing, Rhabdomyosarcoma, Neuroblastoma, Wilms Tumor, Soft Tissue Neoplasms, Uterine Neoplasms, Gestational Trophoblastic Disease, Retinoblastoma, Homocystinuria, Spondylitis, Ankylosing, Arthritis, Gouty, Arthritis, Rheumatoid, Inflammation, Ductus Arteriosus, Patent, Osteoarthritis, Pain, Tendinopathy, Bursitis, Lead Poisoning, Nervous System, Childhood, Cushing Syndrome, Cushing Syndrome

RECORDATI RARE DISEASES INC Diseases Covered